https://clinicaltrials.gov/study/NCT05643638?cond=NCT05643638&rank=1
Interesting.
Doesn't include Turkey?
As I stated previously, that's two P2 trials at the same time for GVHD??
Let the costs begin! Welcome to stem cell trials, FDA style........being run from Australia. And doing Turkey at the same time.
Management has said they have more than enough cash. Ok then.
- Forums
- ASX - By Stock
- Ann: First Patient Treated in Phase 2 GvHD Trial
CYP
cynata therapeutics limited
Add to My Watchlist
3.23%
!
16.0¢

https://clinicaltrials.gov/study/NCT05643638?cond=NCT05643638&ran...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $36.15M |
Open | High | Low | Value | Volume |
16.0¢ | 16.0¢ | 16.0¢ | $11.15K | 69.69K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 70000 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 305 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 70000 | 0.155 |
9 | 230624 | 0.150 |
2 | 105000 | 0.145 |
4 | 530785 | 0.140 |
1 | 2500 | 0.135 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 305 | 1 |
0.165 | 1713 | 1 |
0.170 | 129998 | 2 |
0.180 | 43250 | 1 |
0.185 | 35990 | 1 |
Last trade - 13.17pm 04/07/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online